Alzheimer’s disease CSF biomarkers: clinical indications and rational use
Author:
Funder
EU/EFPIA Innovative Medicines Initiative Joint Undertaking
Publisher
Springer Science and Business Media LLC
Subject
Neurology (clinical),General Medicine
Link
http://link.springer.com/article/10.1007/s13760-017-0816-5/fulltext.html
Reference83 articles.
1. Han JW, Kim TH, Lee SB, Park JH, Lee JJ, Huh Y, Park JE, Jhoo JH, Lee DY, Kim KW (2012) Predictive validity and diagnostic stability of mild cognitive impairment subtypes. Alzheimer’s Dement 8(6):553–559. doi: 10.1016/j.jalz.2011.08.007
2. Koepsell TD, Monsell SE (2012) Reversion from mild cognitive impairment to normal or near-normal cognition: risk factors and prognosis. Neurology 79(15):1591–1598. doi: 10.1212/WNL.0b013e31826e26b7
3. Palmer K, Backman L, Winblad B, Fratiglioni L (2008) Mild cognitive impairment in the general population: occurrence and progression to Alzheimer disease. Am J Geriatr 16(7):603–611. doi: 10.1097/JGP.0b013e3181753a64
4. Petersen RC (2016) Mild cognitive impairment. Continuum 22 (2 Dementia):404–418. doi: 10.1212/CON.0000000000000313
5. Jessen F, Amariglio RE, van Boxtel M, Breteler M, Ceccaldi M, Chetelat G, Dubois B, Dufouil C, Ellis KA, van der Flier WM, Glodzik L, van Harten AC, de Leon MJ, McHugh P, Mielke MM, Molinuevo JL, Mosconi L, Osorio RS, Perrotin A, Petersen RC, Rabin LA, Rami L, Reisberg B, Rentz DM, Sachdev PS, de la Sayette V, Saykin AJ, Scheltens P, Shulman MB, Slavin MJ, Sperling RA, Stewart R, Uspenskaya O, Vellas B, Visser PJ, Wagner M (2014) A conceptual framework for research on subjective cognitive decline in preclinical Alzheimer’s disease. Alzheimer’s Dement 10(6):844–852. doi: 10.1016/j.jalz.2014.01.001
Cited by 91 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Alzheimer Disease Cerebrospinal Fluid Biomarkers in a Tertiary Neurology Practice;Mayo Clinic Proceedings;2024-08
2. Artificial Intelligence in Eye Movements Analysis for Alzheimer’s Disease Early Diagnosis;Current Alzheimer Research;2024-03
3. The Research Progress of the Application of Bioinformatics in the Diagnosis and Treatment of Alzheimer's Disease;Chinese medicine and natural products;2024-03
4. The Bio‐Hermes Study: Biomarker database developed to investigate blood‐based and digital biomarkers in community‐based, diverse populations clinically screened for Alzheimer's disease;Alzheimer's & Dementia;2024-02-28
5. Why to test for dementia: perspectives of patients, significant others and general practitioners;Age and Ageing;2024-01-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3